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Background: The role of oxidative stress in the formation of aneurysms is not fully understood. We used the
complementary DNA (cDNA) microarray technique to determine the transcription profile in the development of
elastase-induced abdominal aortic aneurysm in rat models, with an emphasis on the oxidative stress-related genes.
Materials and Methods: In the experimental group, rat abdominal aortas were perfused with elastase to induce AAA. In the
control group, a sham operation was performed with perfusion of the aortas with saline solution. Four or five animals
were used for each time point for each of the elastase-treated or saline-treated groups. At day 2, day 7, and day 10 after
surgery, the external aortic diameter was measured and AAA formation was estimated. Total RNA was isolated from
aortas and subjected to cDNA microarray analysis with the use of the rat genome U34A high-density oligonucleotide
DNA chip (Affymetrix, Santa Clara, Calif), which contains a total number of 8799 genes of which 2017 are expressed
sequence tag (EST) genes. The data were analyzed with the GENECHIP Data Mining Tool software (Affymetrix). For
genes of interest, reverse-transcription polymerase chain reaction was performed to confirm their expression level.
Results: Comparison ranking analysis revealed that during AAA development, the expression of 212 genes, including 46
of EST genes, increased by more than two-fold and 229 genes, including 95 of EST genes, decreased by more than
two-fold in at least one of the three time points. The regulated genes included those encoding heme oxygenase, inducible
nitric oxide synthase, some extracellular matrix proteins, members of the matrix metalloproteinase family, and those
associated with prooxidant/antioxidant and inflammatory responses. Reverse-transcription polymerase chain reaction
analysis confirmed the upregulation of genes involved in oxidative stress, such as heme oxygenase, inducible nitric oxide
synthase, 12-lipoxygenase, and heart cytochrome c oxydase subunit VIa, and the downregulation of antioxidant genes,
such as superoxide dismutase, reduced nicotinamide adenine dinucleotide–cytochrome b-5 reductase, and glutathion
S-transferase.
Conclusion: The cDNA microarray technique was useful for investigation of the transcription profiles during the
development of AAA. Our results indicate that oxidative stress may play a pivotal role in the pathologic progression of
AAA. (J Vasc Surg 2002;36:379-85.)
Abdominal aortic aneurysm (AAA) represents a poten-
tially fatal disorder that affects 2% to 9% of the population
older than 65 years and remains an important clinical
problem.1 With the clinical features of a deteriorated aortic
wall leading to progressive dilatation and eventual rupture,
AAA results from atherosclerotic change followed by accel-
erated degradation of collagen and elastin, the main com-
ponents of the extracellular matrix (ECM) in the vascular
wall. In addition to these pathologic alterations, AAAs are
associated with marked alterations of the cellular composi-
tion of the aortic wall, such as the infiltration of macro-
phages and T-lymphocytes into the adventitia and the
greatly decreased population of vascular smooth muscle
cells (VSMCs).2,3
To date, the most popular experimental model of AAA
is the elastase-induced aneurysm in the rat model described
by Anidjar et al.4 In this model, the transient intraaortic
infusion of porcine pancreatic elastase causes an inflamma-
tory response in the aortic wall. With such experimental
conditions, the infusion of elastase does not result in a rapid
degradation of the elastic fibers, and generally only mild
dilatation is seen immediately after elastase infusion, fol-
lowed by a later increase in aortic diameter (AD) to aneu-
rysmal proportions.5,6 The associated pathologic events
include the increased transmural infiltration of macrophage
and T-lymphocytes, the production of matrix metallopro-
teinases (MMPs), such as MMP-2, MMP-9, and MMP-12,
and the degradation of the medial elastic lamellae.6-8 Al-
From the Division of Biomedical Sciences, University of California–River-
sidea; the First Department of Surgery, School of Medicine, Chiba Uni-
versityb; the Department of Bioengineering and Whitaker Institute of
Biomedical Engineering, University of California–San Diego.c
Supported in part by research grants HL44147, HL64382 (Chien),
HL56707, and HL60789 (Shyy) from National Heart, Lung, and Blood
Institute. Dr Shyy is Established Investigator of American Heart Associ-
ation.
Competition of interest: nil.
Additional material for this article may be found online at www.mosby.
com/jvs.
Reprint requests: John Y-J. Shyy, PhD, Division of Biomedical Sciences,
University of California–Riverside, Riverside, CA 92521-0121 (e-mail:
john.shyy@ucr.edu).
Copyright © 2002 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2002/$35.00  0 24/1/124366
doi:10.1067/mva.2002.124366
379
though the elastase-induced AAA is not originated from
atherosclerosis, the use of this model has been valuable for
investigation of the pathogenesis of the disease because this
model shares many pathologic features with human AAA.5
An increased body of evidence shows that oxidative
stress caused by reactive oxygen species (ROS) participates
in regulation of endothelium-dependent relaxation and
modulation of VSMC phenotype and secretion of ECM.
All of these events play important roles in vascular diseases,
such as hypertension and atherosclerosis,9 suggesting that
the sources of ROS and the signaling pathways that they
modify may be involved in development of AAA.
Many previous reports have revealed the gene expres-
sion in human AAAs or rat experimental AAAs. Most of
these reports have concentrated on a few genes related to
the pathologic events mentioned previously. The develop-
ment of chip-based or membrane-based complementary
DNA (cDNA) microarrays has made possible the investiga-
tion of the transcription profiles in cells in physiologic or
pathophysiologic conditions.
This study uses the high-throughput cDNA microarray
to determine the genes involved in the pathologic progres-
sion of aneurysmal formation. We found that genes related
to oxidative stress, and those involved in inflammatory
responses, are modulated in the experimental AAA.
MATERIALS AND METHODS
Aneurysm formation. The procedures used in this
study were according to those reported by Yamaguchi et
al,10,11 with slight modifications, and were approved by the
University of California–Riverside Chancellor’s Committee
on Laboratory Animal Care. Male Sprague-Dawley rats
(approximately 300 g) were anesthetized with intraperito-
neal injection of 6% sodium pentobarbital (50 mg/kg).
The infrarenal abdominal aorta was dissected from the
inferior vena cava and other surrounding tissues, and all
lumbar arteries within this portion were ligated. A polyeth-
ylene PE10 catheter (Baxter, Mcgraw Park, Ill) was in-
serted through the left femoral artery into the aorta until
the tip was just about to reach the inferior mesenteric
artery. A ligature was placed around the catheter and the
surrounding aorta, and an aortic clamp was placed at the
distal level of the left renal vein. The isolated segment
(approximately 1 cm) then was perfused continuously with
a syringe pump for 30 minutes; the experimental group
received 1 mL of saline solution containing 15 U/mL of
porcine pancreatic elastase type 1 (Sigma, St Louis, Mo),
and the control group received only 1 mL of saline solu-
tion.10,11 After the perfusion, the left femoral artery was
ligated at the proximal point of the insertion. The wounds
were closed, and the animals were allowed to recover from
anesthesia. On postoperational day (POD) 2, POD7, and
POD10, aortas were resected. The external AD was mea-
sured with a digimatic caliper with the microscope before
and after perfusion and at harvest. The resected aortas were
washed with cold phosphate-buffered saline solution to
remove blood and were preserved in liquid nitrogen until
use. Representative sections from each specimen were sub-
jected to Verhoeff–van Gieson staining and hematoxylin
and eosin staining. The degrees of degradation of elastin
and inflammation in the aneurysm models were assessed
with comparison with the controls.
RNA extraction, array hybridization, scanning, and
data analysis. Total RNA was isolated from the resected
aortas with TRIzol (Life Technology, Grand Island, NY).
Equal amounts of RNA isolated from different animals
within the same subgroup were pooled together. cDNA
was synthesized with an oligo-dT primer attached to a
sequence of the T7 promoter region. cRNA then was
generated with an ENZO biotinylated labeling kit (ENZO
Biochem, New York, NY), followed by fragmentation to an
average size of 100 to 150 bases, which then were hybrid-
ized with a rat genome U34A array (Affymetrix) at 45° C
for 16 hours. The hybridized arrays were washed, stained,
and scanned according to standard protocols. The results
were analyzed with the GENECHIP analysis suite software
(Affymetrix).
Each pooled RNA sample was subjected to two chip
hybridization, and each individual microarray scanning re-
sult was analyzed to determine the expression levels of
individual genes. Comparison ranking analysis was made on
the results among two samples for the experimental group
and two for the controls for each of the three time points.
The detailed procedure of the analysis is described in the
online supplement.
Reverse-transcription polymerase chain reaction.
For confirmation of the results of microarray analysis, re-
verse-transcription polymerase chain reaction (RT-PCR)
was performed on seven oxidative stress-related genes with
the Reverse Transcription System (Promega, Madison,
Wis). The RT reaction with 0.2 g of RNA from the same
pooled samples was performed with the following cycles:
42° C for 60 minutes, 95° C for 5 minutes, and then
cooling to 4° C. For each reaction, cDNA from the RT
reaction was amplified with PCR with the use of 2.5 units of
Taq DNA polymerase (Promega). The PCR cycles for each
reaction were as follows: heat denaturation at 94° C for 1
minute, primer annealing at 55° C for 2 minutes, and
primer extension at 72° C for 3 minutes. Table I (online
only) summarizes the primer sequences of various genes
analyzed and the number of cycles of PCR reaction. The
PCR reactions were carried out in a Gene Amp PCR System
2400 (Applied Biosystems, Foster City, Calif). Aliquots of
each PCR reaction were separated with 2% agarose gels and
revealed with ethidium bromide under ultraviolet light.
The gel was photographed, and the density of DNA bands
was analyzed with National Institutes of Health image
software.
Statistics. The preperfusion, postperfusion and final
AD measurements for the experimental and control groups
were recorded as mean standard error, and the data were
analyzed with the Student t test. For each animal, the
percentage increase of AD was defined as (AD final  AD
preperfusion)/AD preperfusion  100%. The difference
was considered significant at a P value of less than .05.
Statistical analysis for cDNA microarray result was per-
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formed with comparison ranking within software Data
Mining Tool (version 2.0, Affymetrix).
RESULTS
Aneurysm formation. The mean AD of rats in-
creased by 30% to 35% immediately after aortic perfusion
with either elastase or saline solution (Table II). In saline-
perfused controls, the AD subsequently decreased to
within the normal range. In elastase-perfused animals, the
AD was slightly enlarged at POD2 but increased more
markedly thereafter; aneurysmal formation was observed at
POD7, and further enlargement occurred at POD10 in all
animals. The histologic features of these specimens were
consistent with previous reports.6-8
Complementary DNA microarray analysis. De-
pending on the change of fluorescence intensity, the 8799
probe sets in the chip were divided into five groups accord-
ing to the manufacturer’s software: 1, increase (I); 2, mar-
ginal increase (MI); 3, no change (NC); 4, marginal de-
crease (MD); and 5, decrease (D). From four comparisons
between the elastase-treated and the corresponding saline-
treated groups (two chips each), the genes whose expres-
sion level was either (I) or (D) in both chips were denoted
as being up-regulated or down-regulated, respectively. The
degree of change for each gene in the (I) or (D) groups
then was averaged from the two paired measurements, and
only those with a change greater than 2.0 or smaller than
2.0 were selected.
After comparison ranking analysis, up-regulated or
down-regulated genes were selected from those encoding
for known genes. At POD2, POD7, and POD10, the
numbers of up-regulated genes were 97, 68, and 79, re-
spectively, and those of down-regulated genes were 65, 84,
and 60, respectively. Fourteen genes were induced and 15
were suppressed at both POD2 and POD7, 18 genes were
induced and five suppressed at both POD2 and POD10,
and 18 genes were induced and 15 suppressed at both
POD7 and POD10. Fourteen genes were consistently in-
duced and 20 were consistently suppressed during the
course of AAA, namely, at POD2, POD7, and POD10
(Tables III and IV, online only).
Among the up-regulated or down-regulated genes,
those related to vascular biology or immune/inflammation
conditions are listed in Tables V and VI. These included 28
increased and 15 decreased expressions in the elastase-
induced rat AAA. The genes whose expressions increased at
all these time points were interleukin-6, plasminogen acti-
vator inhibitor–1, and urokinase type plasminogen activa-
tor receptor–1. Inducible nitric oxide synthase (iNOS),
interleukin-1, macrophage inflammatory protein–2 pre-
cursor, DORA protein, and collagenase were up-regulated
at both POD2 and POD7. The genes in which expression
increased at both POD7 and POD10 include heme oxy-
genase (HO) and heart cytochrome c oxidase subunit VIa.
The expression of 12-lipoxygenase and CXC chemokine
receptor increased at both POD2 and POD10. Among
suppressed genes, down-regulated at all time points were
superoxide dismutase (SOD), epididymal secretory super-
oxide dismutase, reduced nicotinamide adenine dinucle-
otide (NADH)–cytochrome b-5 reductase, glutathione S-
transferase (GST), tropoelastin, SC1 extracellular matrix
glycoprotein, SM22, myosin regulatory light chain isoform
C, and alternatively spliced smooth muscle myosin heavy
chain.
At POD2, POD7, and POD10, the total numbers of
up-regulated expressed sequence tag (EST) genes were 7,
16, and 8, and those of down-regulated EST genes were
34, 18, and 10, respectively. Three genes were commonly
induced and six were suppressed at both POD2 and POD7,
two genes were induced and eight were suppressed at both
POD2 and POD10, and five genes were induced and 11
were suppressed at both POD7 and POD10. Five genes
were consistently induced and eight were consistently sup-
pressed at POD2, POD7, and POD10. Table VII (online
only) shows the gene list of Affymetrix Rat genome U34A
chip, and the tables of up-regulated and down-regulated
EST genes are in Tables VIII and IX (online only).
Reverse-transcription polymerase chain reaction
confirmation. The results from cDNA microarray analysis
were confirmed with RT-PCR for seven genes related to
oxidative stress. At POD2 and POD7, the iNOS messenger
RNA (mRNA) level in the elastase-treated specimens was
greater than that in controls perfused with saline solution.
The level of HO mRNA was increased at all time points.
The expression of the 12-lipoxygenase gene was up-regu-
lated in the elastase group at POD2 and POD10, and that
of the cytochrome b558 -subunit genes was induced at
POD2. The RT-PCR results for SOD, NADH-cytochrome
Table II. AD measurements in elastase-perfused or saline-perfused aortas
Group AD before (mm) AD after (mm) AD final (mm) AD increase (%)
C-2 (n  4) 1.37  0.06 1.78  0.02 1.68  0.02 22.6  4.0
E-2 (n  4) 1.28  0.05 1.72  0.11 2.58  0.14* 102  7.6*
C-7 (n  5) 1.36  0.08 1.85  0.19 1.62  0.13 19.1  7.4
E-7 (n  4) 1.31  0.02 1.80  0.02 6.54  0.71* 398  57*
C-10 (n  4) 1.39  0.07 1.75  0.05 1.56  0.06 12.3  1.7
E-10 (n  4) 1.36  0.08 1.80  0.09 9.36  1.24* 589  58*
Numbers in parentheses indicate days after operation. AD before and AD after diameters measured before perfusion or 5 minutes after blood restoration,
whereas AD final diameters at resection.
*P 	 .05 when compared with parallel saline-perfused controls and with other two elastase-treated groups.
C, Saline-perfused controls, E, elastase-treated experimental group.
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b5 reductase, and GST showed a reduced mRNA level in
the experimental group compared with controls at each
time point. As shown in Fig, all the PCR results agreed well
with those of the microarray analysis (Tables V and VI),
except that the time course of the change in the HO mRNA
was reversed between the RT-PCR and the microarray
analysis. Serving as a control, glyceraldehyde-phosphate
dehydrogenase mRNA showed similar levels in all experi-
ments, which not only indicated that the reduced glyceral-
dehyde-phosphate dehydrogenase gene was not affected
during AAA but also validated the RT-PCR experimental
procedures.
DISCUSSION
The use of elastase-induced AAA in the rat model has
facilitated the investigation of transcription regulation dur-
ing the onset of AAA. Genes encoding for the MMP family,
ECM proteins, cytokines, cycloxygenase-2, and iNOS have
been reported to be up-regulated in rat AAAs.12,13 Most of
these reports focused on a small number of genes, and
information is lacking on the temporal responses of these
genes. The advancement of cDNA microarray has allowed a
high-throughput survey of gene expression during the
pathogenesis of many diseases, including atherosclerosis
and aneurysm.14,15 Recently, a microarray study investi-
gated the expression profile of human AAA compared with
specimens from young organ transplant donors.15 We
compared the data generated from this study and those
from the previous human AAAs. Only a few genes (eg,
gelatinase B and CXC chemokine receptor) are commonly
modulated in our rat models and in human AAA. One
possible explanation is that our samples were harvested
during the process of AAA formation, whereas those in the
study of Tung, Lee, and Thompson15 can be regarded as
“completed” AAAs. Thus, gene expression profile may be
dependent on distinct periods during development of AAA.
Oxidative stress contributes to various cardiovascular
diseases,9 but little information is available on the role of
oxidative stress-related genes in AAA. In this study, we
showed that the iNOS and HO genes are induced at POD2
and POD7 and at POD7 and POD10, respectively. NO,
modulated by iNOS, plays a pivotal role in cardiovascular
homeostasis, atherosclerosis, and inflammatory responses.
One of the mechanisms with which nitric oxide (NO)
mediates tissue damage is the enhancement or amplifica-
tion of the effects of proinflammatory cytokines on various
cell types, which in turn may increase the expression and
enzymatic activity of MMPs.16,17 In addition, NO can
Table V. Up-regulated genes during AAA formation and their fold of change
Gene (Genbank No.) POD2 POD7 POD10
Oxidative stress
iNOS (U03699) 52 5.2 NC
iNOS2 (U48829) 10 NC NC
iNOS (D44591) 27 NC NC
Argininosuccinate synthetase (X12459) 5.6 NC NC
Heme oxygenase (J02722) NC 3 10
12-Lipoxygenase (S69383) 4 NC 2.6
Cytochrome b558 -subunit (U18729) 2.6 NC NC
Oxidative stress-inducible protein tyrosine phosphatase (S81478) 4.3 NC NC
5-Lipoxygenase activating protein (X52196) 3.2 NC NC
Heart cytochrome c oxidase subunit VIa (X12554) NC 3.9 2.7
Inflammation
Interleukin-6 (M26744) 13 15 5.7
Interleukin-1 (D00403) 8.4 NC NC
Interleukin-1 (E01884) 37 5.5 NC
Interleukin-1 (M98820) 23 6 NC
Interleukin-1 receptor type 2 (Z22812) 10 9.1 NC
CXC chemokine receptor (U90610) 3.7 NC 4.2
CC chemokine receptor protein (E13732) 5 NC NC
CXC chemokine LIX (U90448) NC 8.9 NC
Tumor necrosis factor I receptor (AA900380) 8.5 NC NC
Macrophage inflammatory protein-1 (U22414) 39 NC NC
Macrophage inflammatory protein-2 precursor (U45965) 40 5.5 NC
DORA protein (AJ223184) 5.4 3.9 NC
Fibrinolysis
Plasminogen activator inhibitor-1 (M24067) 2.4 7.1 3
Urinary plasminogen activator receptor (X71898) 13.6 3.5 9.8
MMP family
Gelatinase B (MMP-9) (U24441) 5.9 NC NC
Macrophage metalloelastase (MMP-12) (X98517) 5.3 –5.5* –2.7*
Neutrophil collagenase (MMP-8) (AJ007288) 3.6 NC NC
Collagenase (M60616) 4.8 12.2 NC
*Gene expression was decreased at POD7 and 10.
NC, No change.
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cause tissue damage through the nitration of ECM proteins
in vivo18 and can induce Fas-mediated VSMC apoptosis in
vitro.19 The induction of the iNOS gene is consistent with
the previous observation that a selective blocking NO
production with aminoguanidine reduces the aneurysm
size in elastase-induced rat AAAs.13 However, AAA is still
induced with elastase in the iNOS-deficient mice.16 Thus,
the role of NO and iNOS in this model remains to be
elucidated. Another diatomic gas molecule involved in
tissue damage is carbon monoxide (CO), which is pro-
duced as a byproduct of heme catabolism catalyzed by HO.
Through a cyclic guanosine monophosphate–dependent
mechanism, CO is similar to NO in causing blood vessel
relaxation and platelet inhibition.20,21 Furthermore, NO
can enhance HO activity to generate biliverdin, which is
subsequently converted to bilirubin with biliverdin reduc-
tase.22 Both biliverdin and bilirubin are efficient scavengers
of ROS and hence lead to cellular defense mechanisms
against oxidative tissue injury.23,24 The temporal responses
of iNOS and HO indicate that, although the generated NO
and CO may be important in initiating tissue injury, the
induction of HO may also exert protective effects during
the AAA formation.
Several other genes related to ROS production were
found to be modulated in our study. The level of cyto-
chrome b558 -subunit, a subunit of NADH oxidase, was
increased at POD2. NADH oxidase is the main enzyme
generating ROS in vascular tissues.25 The level of 12-
lipoxygenase, which causes intracellular membrane degen-
eration,25 was increased at POD2 and POD10. However,
12-lipoxygenase was down-regulated at POD7, and this
was confirmed with RT-PCR. The reason for this biphasic
modulation of 12-lipoxygenase during AAA formation is
unknown. Interestingly, the expression of several genes
encoding for antioxidants, such as the SOD, NADH-cyto-
chrome b5 reductase, and GST genes, was decreased
throughout the experimental period. The distinct expres-
sion profiles of prooxidant and antioxidant genes would
result in an imbalance between ROS production and free
radical scavenge. As a result of the impaired redox state,
oxidative damage may accelerate the formation of AAA.
This notion is supported with the observation that an
imbalance between prooxidants and antioxidants induces
VSMC apoptosis after an acute vascular injury.26 Although
we were not able to detect the increase in the apoptosis-
related genes, such as Fas or caspase family members, the
down-regulation of genes encoding for VSMC cytoskeletal
proteins, such as SM-22, and those encoding ECM pro-
teins, such as tropoelastin, can be related to a reduction of
VSMCs during AAA formation. Taken together, our re-
sults may imply that oxidative stress is induced during the
process of AAA, which leads to tissue injury and VSMC
apoptosis.
A number of genes involved in the inflammatory re-
sponse, such as cytokines and their receptors, lymphocyte
cell surface antigens, and immunoglobulin, were induced.
Some of these genes, for example, interleukin-6 or inter-
leukin-1, are known to be involved in human or experi-
mental AAAs.27-29 The mRNA levels of interleukin-6, in-
terleukin-1, and tumor necrosis factor– are up-regulated
by ROS in a dose-dependent manner.30 Thus, AAA forma-
tion can be modulated by ROS in many ways. Apparently,
other proinflammatory genes shown in Table V also corre-
late with the pathogenesis of AAA. These genes and the
MMP family members had their highest expression at
POD2, just before the onset of the large increase in AD,
which suggests that, like MMPs, these proinflammatory-
related proteins play an important role in promoting AAA.
We showed that the expression of MMP-12 was increased
at POD2 but decreased at POD7 and POD10. In addition,
the expression of all other MMPs shown in Table V de-
creased at POD10 to the levels of the sham controls. The
Table VI. Down-regulated genes during AAA formation and fold of change
No. gene (Genbank) POD2 POD7 POD10
Antioxidative stress
SOD (Z24721) 6.4 8.9 21
Epididymal secretory superoxide dismutase (X68041) 8.9 5.6 12
NADH-cytochrome b-5 reductase (J03867) 2.7 2.3 2.8
NADH-cytochrome b-5 reductase (D00636) 2.5 6.6 11
GST (J03752) 2.2 3.2 2.8
ECM
Tropoelastin (J04035) 2.4 3.3 4.2
SC1 protein (U27562) 68 19 61
Tenascin-X (U24489) NC 6.9 9.6
Fibromodulin (X82152) 2.9 NC 2
TSP-4 protein (X89963) 4.6 NC NC
Cytoskeleton
SM22 (M83107) 4 3.6 2.4
Myosin regulatory light chain isoform C (S77900) 3.4 2.3 3.5
Alternatively spliced SM myosin heavy chain (X16262) 5 4.1 6.3
-Actinin-2 associated LIM protein (AF002281) 3.5 5 NC
Smooth muscle cell LIM protein (SmLIM) (U44948) 2.5 NC NC
NC, No change.
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mechanism underlying a temporal decrease in the gene
expression of some MMPs is of interest. The link between
changes in oxidative stress and the altered activities of the
secreted MMPs deserves further study.
In this study, the limited availability of RNA from the
rat aortas, especially in the controls, led to the combination
of samples from different rats, thus imposing a statistical
limitation in analyzing the microarray results. In microarray
screening of gene expression, validation of the results with
methods such as Northern blotting or RT-PCR is neces-
sary. With the use of RT-PCR, we confirmed the microar-
ray analysis of expression levels of oxidative stress-related
genes during AAA development. Future studies, with ROS
inhibitors or gene-deleted animal models, will be needed to
establish the precise roles of genes in the pathogenesis of
AAA. In addition, investigations of the roles of the uniden-
tified ESTs in this disease also will be fruitful.
In summary, this study provides evidence of the utility
of a genome-wide cDNA microarray screening to identify
candidate genes involved in the etiology of AAA. Our data
suggest that oxidative stress-imposed injury may be one of
the key events leading to AAA formation. The role of ROS
in inducing multiple pathways to promote AAA formation
can be studied further with the use of ROS inhibitors to
attenuate the AAA size.
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